If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...